Presentation by Dr Philippe Douste-Blazy. Chair of UNITAID Special Representative of the UN SG for Innovative Financing for Development

Similar documents
UNITAID (A new innovative mechanism for scaling up access to medicines and diagnostics for HIV/AIDS, TB and malaria)

UNITAID is hosted and administered by the World Health Organization

Funding for AIDS: The World Bank s Role. Yolanda Tayler, WB Bi-regional Workshop for the Procurement of ARVs Phnom Penh, Cambodia

Diagnostic Procurement The Clinton Foundation HIV/AIDS Initiative

HIV DIAGNOSTIC TESTS IN LOW- AND MIDDLE-INCOME COUNTRIES: FORECASTS OF GLOBAL DEMAND FOR

Malaria Funding. Richard W. Steketee MACEPA, PATH. April World Malaria Day 2010, Seattle WA

PROGRESS REPORT ON THE ROAD MAP FOR ACCELERATING THE ATTAINMENT OF THE MILLENNIUM DEVELOPMENT GOALS RELATED TO MATERNAL AND NEWBORN HEALTH IN AFRICA

UNITAID Annual Report 2009

Eligibility List 2018

Global Plan towards the elimination of new HIV infections among children by 2015 and keeping their mothers alive

Health systems and HIV: advocacy. Interagency Coalition on AIDS and Development

Global Fund Mid-2013 Results

UNAIDS 2013 AIDS by the numbers

Aboubacar Kampo Chief of Health UNICEF Nigeria

An innovative mechanism for scaling up access to medicines and diagnostics for HIV/AIDS, tuberculosis and malaria

Global Fund ARV Fact Sheet 1 st June, 2009

Annex 2 A. Regional profile: West Africa

Renewing Momentum in the fight against HIV/AIDS

Pneumococcal Conjugate Vaccine: Current Supply & Demand Outlook. UNICEF Supply Division

Current State of Global HIV Care Continua. Reuben Granich 1, Somya Gupta 1, Irene Hall 2, John Aberle-Grasse 2, Shannon Hader 2, Jonathan Mermin 2

AIDS in Africa. An Update. Basil Reekie

Analysis of Immunization Financing Indicators from the WHO-UNICEF Joint Reporting Form (JRF),

מדינת ישראל. Tourist Visa Table

Update on PMTCT. African Health Profession Regulatory Collaborative for Nurses and Midwives. Johannesburg, Republic of South Africa, June 18-22, 2012

Comparative Analyses of Adolescent Nutrition Indicators

Fighting Harder and Smarter Against Malaria. Dr.Bernard Nahlen Deputy US Global Malaria Coordinator University of Georgia, February 23, 2010

What is this document and who is it for?

Expert Group Meeting on Strategies for Creating Urban Youth Employment: Solutions for Urban Youth in Africa

SGCEP SCIE 1121 Environmental Science Spring 2012 Section Steve Thompson:

Impact Dashboard - October 2014

POLIOMYELITIS ERADICATION: PROGRESS REPORT. Information Document CONTENTS BACKGROUND PROGRESS MADE NEXT STEPS... 12

COLD CHAIN EQUIPMENT OPTIMISATION PLATFORM (CCEOP)

The Challenge of Malaria

Impact Dashboard - August 2014

Global Fund Results Fact Sheet Mid-2011

מדינת ישראל. Tourist Visa Table. Tourist visa exemption is applied to national and official passports only, and not to other travel documents.

Sourcing of ARVs & HIV diagnostics. Procurement for Impact P4i

ANNEX 3: Country progress indicators

Tipping the dependency

JOINT TB AND HIV PROGRAMMING

Lessons learned from the IeDEA West Africa Collaboration

THE CARE WE PROMISE FACTS AND FIGURES 2017

February Health Impact Report 2010

10 Years of Laboratory Capacity Building. September 6-11 th, 2015 Les Pensieres, Veyrier-du-Lac, France

Evolving Realities of HIV Treatment in Resource-limited Settings

Prioritizing Emergency Polio Eradication Activities

HIV/AIDS - Getting Results

Accelerating Children s HIV Treatment (ACT): Rationale, Progress & Challenges

Outcomes of the Global Consultation Interim diagnostic algorithms and Operational considerations

TURNING POINT FOR AFRICA AN HISTORIC OPPORTUNITY TO END AIDS AS A PUBLIC HEALTH THREAT BY 2030 AND LAUNCH A NEW ERA OF SUSTAINABILITY

APPENDIX II - TABLE 2.3 ANTI-TOBACCO MASS MEDIA CAMPAIGNS

Elimination of mother to child transmission of HIV: is the end really in sight? Lisa L. Abuogi, MD University of Colorado, Denver Dec 3, 2014

PROGRESS ON HEALTH-RELATED MILLENNIUM DEVELOPMENT GOALS AND THE POST 2015 HEALTH DEVELOPMENT AGENDA. Report of the Secretariat CONTENTS ANNEXES

Main global and regional trends

Copyright 2011 Joint United Nations Programme on HIV/AIDS (UNAIDS) All rights reserved

Financing the HIV response in sub- Saharan Africa from domestic sources: moving beyond a normative approach

PRIORITIES FOR HIV/AIDS PROCUREMENT AND PRODUCT DEVELOPMENT

Children in Africa. Key statistics on child survival, protection and development

October 2011 Monthly Health Impact Report

GABON. Neglected tropical disease treatment report profile for mass treatment of NTDs

ASLM Building laboratory capacity in Africa in a sustainable way

Update from GAVI Aurelia Nguyen

EXPLANATION OF INDICATORS CHOSEN FOR THE 2017 ANNUAL SUN MOVEMENT PROGRESS REPORT

Financial Resources for HIV: PEPFAR s Contributions to the Global Scale-up of Treatment

Copyright 2011 Joint United Nations Programme on HIV/AIDS (UNAIDS) All rights reserved ISBN

Progress Report: Universal Access Target Setting in East and Southern Africa

STATUS REPORT ON MALARIA

Procedure for Expedited Review of imported pre-qualified vaccines for use in national immunization programmes

Challenges and Opportunities to Optimizing the HIV Care Continuum Can We Test and Treat Enough People to Make a Seismic Difference by 2030?

Ouagadougou Declaration

Financing malaria control

Status Report on WSS MDG Roadmaps and Country Status Overviews WSP Africa

Elimination of New HIV Infections among Children by 2015 and Keeping their Mothers Alive:

Gender, Poverty, and Health in Sub-Saharan Africa: A Framework for Analysis

2. Treatment coverage: 3. Quality of care: 1. Access to diagnostic services:

impact dashboard - august 2018

The Global Fund & UNICEF Partnership

Sexual and reproductive health care: A comparison of providers and delivery points between the African Region and other regions

IMMUNIZATION VACCINES & EMERGENCIES

ACCESS 7. TOWARDS UNIVERSAL ACCESS: THE WAY FORWARD

Why Invest in Nutrition?

Maternal, Newborn and Child Health: Global initiatives and priority products for MNCH Dr. Mark W. Young Senior Health Specialist, UNICEF-New York

511,000 (57% new cases) ~50,000 ~30,000

25 October 2005 INTRODUCTION

Scaling Up Nutrition Action for Africa

PROGRESS REPORT ON CHILD SURVIVAL: A STRATEGY FOR THE AFRICAN REGION. Information Document CONTENTS

Progress Towards the Child Mortality MDG in Urban Sub-Saharan Africa. Nyovani Janet Madise University of Southampton

CALLING ABROAD PRICES FOR EE SMALL BUSINESS PLANS

Progress has been made with respect to health conditions.

D TA companion & Scorecard. to the UNICEF Gender Action Plan. May 2016

AFRICAN PLAN TOWARDS THE ELIMINATION OF NEW HIV INFECTIONS AMONG CHILDREN BY 2015 AND KEEPING THEIR MOTHERS ALIVE

What Really Works for Raising African Women Leaders in Global Health

Investing for Impact Prioritizing HIV Programs for GF Concept Notes. Lisa Nelson, WHO Iris Semini, UNAIDS

Six things you need to know

Rotavirus Vaccine: Supply & Demand Update. UNICEF Supply Division

Okinawa, Toyako, and Beyond: Progress on Health and Development

Delivering on the MDGs: the MAF in Action

Global reductions in measles mortality and the risk of measles resurgence

Transcription:

Presentation by Dr Philippe Douste-Blazy Chair of UNITAID Special Representative of the UN SG for Innovative Financing for Development

The Millennium Goals : Hope for Humanity 2000 UN Millennium Summit : The General Assembly of the United Nations adopted the Millennium Declaration. 8 Goals linked to 18 quantified targets

The Millennium Goals : Hope for Humanity How the MDGs have changed aid to development: Focus global aid to development action Emphasize the importance of quality Consensus agenda about where action is needed

The Millennium Goals : a hope for Humanity 2000 UN Millennium Summit: the General Assembly of the United Nations adopted the Millennium Declaration. Urgency to free our fellow men, women and children from the abject and dehumanizing conditions of extreme poverty to which more than a billion of them are currently subjected. 8 Goals linked to 18 quantified targets

Progress at mid point In 2005, aid rose to a record $106.8 billion but in real terms, official aid dropped by 5.1%

Percentage of HIV Spending according to type of activity and Region 100% 80% 60% 40% All Other Care and Treatment Prevention 20% 0% *No of countries included: LA: 13, AP: 8, Carib: 3, SSA: 13, EECA: 9, MENA: 3.

Europe as a donor to the Global Fund Pledges and contributions 2002-2010 and beyond Total USD 19.5 billion 10% 4% EU Member States European Commission Other European countries 21% 4% 6% 55% United States Canada, Japan and others Private sector, UNITAID, D2H

Global Fund: HIV/AIDS coverage After 7 Rounds of proposals 133 countries 214 components US$ 3.1 billion (2 years) 0 2,500 5,000 Kilometers US$ 8.6 billion (5 years) 9 Note: HIV/TB, integrated, and HSS components are included. BG/261107/7

Funding for development US$ 2000 2004 2008 2011 2015 10

Innovative Financing for Health UNITAID a lab for innovative financing

Tax received on each ticket by UNITAID (in France) Flight in France or in Europe International flight Economy class First class or business 1 10 Antimalarial treatment for 2 children ex: flight Paris - Berlin 4 40 1 HIV-positive child under treatment for 1 year ex: flight Paris - Dakar An aircraft with 300 passengers on board leaving from Paris will cover the treatment for 1 person with multi drug resistant tuberculosis (approx. 4.000 $) or 60 HIV-positive children for one year Furthermore no economic impact on air traffic

UNITAID: a lab for innovative financing UNITAID September 2006: Official launch of UNITAID in New York with the representatives of the 5 founding countries: Brazil Chile France Norway United-Kingdom

Five founding countries (September 2006) Official signature of the five founding countries when UNITAID was launched, on 19 September 2006, at the United Nations General Assembly, New York

Now UNITAID counts 27 countries From 5 founding countries: Brazil, Chile, France, Norway, UK Now: 27 member countries & the Gates foundation

UNITAID : a lab for innovative financing Over $600 million collected in less than 2 years mainly through air travel tax No economic distortion for the air industry A solidarity movement

UNITAID: a lab for the innovative financing What is innovative about UNITAID? Fills some of the funding gap by targeting niche markets Stable and sustainable Disburses funds rapidly for greater and faster impact Predictable funding Results-oriented

UNITAID: a lab for innovative financing Three times more treatments for children with HIV Three out of four children on therapy for HIV globally treated with UNITAID funds For PMTCT $70 million committed in 17 countries Renutrition programmes Price reductions of up to 60% 70 000 patients supplied with second line ARVs in 20 countries

Ongoing UNITAID programs - HIV/AIDS 35.5 M$ Pediatric ARV: 100,000 new HIV-positive children under adapted ARV treatments in 2007 in 38 countries (40,000 previously treated only, when 660,000 estimated in need). Partner: Clinton Foundation 35.9 M$ 2 nd line ARV: price reduction for 7 products and treatments for 70,000 new patients in 27 countries in 2007. Partner: Clinton Foundation 20.9 M$ Prevention of mother to child transmission: Improve care, reduce prices of diagnostics, 1.2 million pregnant women diagnosed and 340,000 under ARV treatment in 8 countries in 2007-2008. Partners: WHO and UNICEF

UNITAID ongoing actions More than 80 countries already receive UNITAID support HIV / AIDS 51 recipient countries Malaria 22 recipient countries Tuberculosis 58 recipient countries - Pediatric ARV - Second line ARV - PMTCT - ACT - First line TB - Pediatric TB - MDR-TB

51 recipient countries from UNITAID funds against HIV/AIDS AFRO Angola Benin Botswana Burkina Faso Burundi Cameroon Chad DRC Cote d'ivoire Ethiopia Ghana Guinea Kenya Lesotho Liberia Malawi Mali Mozambique Namibia Nigeria Rwanda Senegal Swaziland Tanzania Togo Uganda Zambia Zimbabwe SEARO India WPRO Cambodia China Lao Papua New Guinea Vietnam AMRO Dominican Rep. Guyana Haiti Jamaica OECS (Anguilla, Dominica, St Lucia, Antigua & Barbuda, Grenada, St Christopher & Nevis, British Virgin Islands, Montserrat, St Vincent & Grenadines) EURO Moldova Serbia EMRO Djibouti Morocco Tunisia

UNITAID initiatives have already driven major price reductions (partnering with CHAI) Change in peds ARV prices (AZT FDC vs. individual syrups) US$/patient per year Change in 2 nd -line ARV prices (TDF+3TC) US$/patient per year $$130 $315 50% 50% $66 $159 2006 Q1 2008 2006 Q1 2008 22

Better products at lower price Before: Single dose syrups 16 bottles of syrup monthly 200 $ per patient per year Now (UNITAID-CHAI): Fixed dose combination 3 tablets a day 60 $per patient per year

www.unitaid.eu

Thank you